SecProbe.io

CORRESP
1
filename1.htm

October
7, 2022

Securities
and Exchange Commission

100
F. Street, NE

Washington,
D.C. 20549

    Re:
    Novo
    Integrated Sciences, Inc.

    Registration
    Statement on Form S-1

    File
    No. 333-267401

VIA
EDGAR

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as
amended, Maxim Group LLC, as placement agent, hereby requests acceleration of the effective date of the above-referenced Registration
Statement so that it will become effective at 5:00 p.m., Washington D.C. time, on Wednesday, October 12, 2022, or as soon thereafter
as practicable.

The
following is supplemental information supplied under Rule 418(a)(7) and Rule 460 under the Securities Act of 1933:

    (i)
    Date
    of preliminary prospectus: September 13, 2022.

    (ii)
    Dates
    of distribution: October 4, 2022 through the date hereof.

    (iii)
    Number
    of prospective underwriters and selected dealers to whom the preliminary prospectus was furnished: 1.

    (iv)
    Number
    of prospectuses so distributed: 79.

The
undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating
dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended,
in connection with the above-referenced issue.

    MAXIM
    GROUP LLC

    By:
    /s/
    Clifford Teller

    Name:
    Clifford
    Teller

    Title:
    Executive
    Managing Director